VG Life Sciences Company
VG Life Sciences discovers and develops drug therapies for cancers, infectious diseases, inflammatory diseases, and autoimmune disorders.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
South Pasadena, California, United States
Founded Date:
1995
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
1
Total Funding:
$2.8M
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership